| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kyverna Therapeutics, Inc. | Former 10% Owner | Common Stock | 2,805,426 | 12 Feb 2024 | By: Northpond Ventures III, LP | ||
| Kyverna Therapeutics, Inc. | Former 10% Owner | Common Stock | 450,000 | 12 Feb 2024 | By: Northpond Ventures, LP | ||
| Kyverna Therapeutics, Inc. | Former 10% Owner | Series B Preferred Stock | 0 | 12 Feb 2024 | By: Northpond Ventures III, LP |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KYTX | Kyverna Therapeutics, Inc. | 12 Feb 2024 | 3 | +$9,900,000 | 4 | Former 10% Owner | 12 Feb 2024, 17:51 |
| KYTX | Kyverna Therapeutics, Inc. | 07 Feb 2024 | 0 | $0 | 3 | 10%+ Owner | 07 Feb 2024, 20:30 |